| Product Code: ETC12463521 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Imatinib Drug Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Imatinib Drug Market - Industry Life Cycle |
3.4 Serbia Imatinib Drug Market - Porter's Five Forces |
3.5 Serbia Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Serbia Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Serbia Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Serbia Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Serbia Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Serbia |
4.2.2 Growing awareness and adoption of targeted therapy for cancer treatment |
4.2.3 Favorable government initiatives to improve access to advanced cancer treatments |
4.3 Market Restraints |
4.3.1 High cost of imatinib drug leading to affordability issues for patients |
4.3.2 Stringent regulatory requirements for approval and distribution of oncology drugs in Serbia |
5 Serbia Imatinib Drug Market Trends |
6 Serbia Imatinib Drug Market, By Types |
6.1 Serbia Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Serbia Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Serbia Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Serbia Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Serbia Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Serbia Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Serbia Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Serbia Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Serbia Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Serbia Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Serbia Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Serbia Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Serbia Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Serbia Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Serbia Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Serbia Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Serbia Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Serbia Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Serbia Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Serbia Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Serbia Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Serbia Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Serbia Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Serbia Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Serbia Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Serbia Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Serbia Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Serbia Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Serbia Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Serbia Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Serbia Imatinib Drug Market Import-Export Trade Statistics |
7.1 Serbia Imatinib Drug Market Export to Major Countries |
7.2 Serbia Imatinib Drug Market Imports from Major Countries |
8 Serbia Imatinib Drug Market Key Performance Indicators |
8.1 Percentage of cancer patients opting for targeted therapy in Serbia |
8.2 Number of oncology clinics offering imatinib drug treatment |
8.3 Rate of reimbursement for imatinib drug by health insurance providers |
9 Serbia Imatinib Drug Market - Opportunity Assessment |
9.1 Serbia Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Serbia Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Serbia Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Serbia Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Serbia Imatinib Drug Market - Competitive Landscape |
10.1 Serbia Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Serbia Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here